Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis.
作者信息
Cai Zhuo Ran, Chen Michael L, Weinstock Martin A, Kim Youn H, Novoa Roberto A, Linos Eleni
机构信息
Program for Clinical Research and Technology, Stanford University, Stanford, California.
Department of Dermatology, Stanford University School of Medicine, Stanford, California.
出版信息
JAMA Oncol. 2022 Nov 1;8(11):1690-1692. doi: 10.1001/jamaoncol.2022.3236.
Abstract
摘要
相似文献
1
Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis.2000年至2018年美国原发性皮肤T细胞淋巴瘤的发病率趋势：一项监测、流行病学和最终结果（SEER）人群数据分析
JAMA Oncol. 2022 Nov 1;8(11):1690-1692. doi: 10.1001/jamaoncol.2022.3236.
2
Changing incidence trends of cutaneous B-cell lymphoma.皮肤B细胞淋巴瘤发病率趋势的变化
J Invest Dermatol. 2014 Mar;134(3):840-842. doi: 10.1038/jid.2013.393. Epub 2013 Sep 13.
3
Epidemiology of primary cutaneous γδ T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis.2006年至2015年美国原发性皮肤γδ T细胞淋巴瘤和皮下脂膜炎样T细胞淋巴瘤的流行病学：一项监测、流行病学和最终结果-18分析
Br J Dermatol. 2019 Oct;181(4):848-850. doi: 10.1111/bjd.17985. Epub 2019 Jul 10.
4
Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.1992 年至 2011 年 CTCL 患者的第二原发恶性肿瘤：基于 SEER 的、基于人群的研究，评估 CTCL 诊断时的时间、年龄、性别、分期和 CD30+亚型。
Am J Clin Dermatol. 2016 Feb;17(1):71-7. doi: 10.1007/s40257-015-0155-3.
5
Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.儿童、青少年和青年原发性皮肤恶性肿瘤发病率的趋势：一项基于人群的研究。
Pediatr Blood Cancer. 2014 Feb;61(2):211-6. doi: 10.1002/pbc.24639. Epub 2013 Oct 30.
6
Changing incidence trends of cutaneous T-cell lymphoma.皮肤 T 细胞淋巴瘤发病率变化趋势。
JAMA Dermatol. 2013 Nov;149(11):1295-9. doi: 10.1001/jamadermatol.2013.5526.
7
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.1973 - 2002年美国皮肤T细胞淋巴瘤的发病率
Arch Dermatol. 2007 Jul;143(7):854-9. doi: 10.1001/archderm.143.7.854.
8
Age, race, sex, stage, and incidence of cutaneous lymphoma.年龄、种族、性别、分期和皮肤淋巴瘤的发病情况。
Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):291-6. doi: 10.1016/j.clml.2012.06.010.
9
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.美国皮肤淋巴瘤的发病模式：一项基于人群的3884例病例研究。
Blood. 2009 May 21;113(21):5064-73. doi: 10.1182/blood-2008-10-184168. Epub 2009 Mar 11.
10
Ethnic disparity in primary cutaneous CD30 T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer database.原发性皮肤CD30 T细胞淋巴增殖性疾病中的种族差异：对美国国家癌症数据库中1496例病例的分析
Br J Haematol. 2018 Jun;181(6):721-722. doi: 10.1111/bjh.15221. Epub 2018 Apr 20.
引用本文的文献
1
An Update on Single-Cell RNA Sequencing in Illuminating Disease Mechanisms of Cutaneous T-Cell Lymphoma.单细胞RNA测序在揭示皮肤T细胞淋巴瘤疾病机制方面的最新进展
Cancers (Basel). 2025 Sep 5;17(17):2921. doi: 10.3390/cancers17172921.
2
Janus kinase inhibitors - a role for the treatment of cutaneous T-cell lymphomas?Janus激酶抑制剂——在皮肤T细胞淋巴瘤治疗中的作用？
Oncol Rev. 2025 Aug 11;19:1482866. doi: 10.3389/or.2025.1482866. eCollection 2025.
3
Skin-Directed Therapies in Mycosis Fungoides: An Update.蕈样肉芽肿的皮肤定向治疗：最新进展
Dermatol Ther (Heidelb). 2025 Aug 14. doi: 10.1007/s13555-025-01511-1.
4
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.蕈样肉芽肿、塞扎里综合征和皮肤B细胞淋巴瘤：2025年诊断、风险分层及管理的最新进展
Am J Hematol. 2025 Sep;100(9):1603-1628. doi: 10.1002/ajh.27735. Epub 2025 Jun 10.
5
Atopic dermatitis and lymphoma risk: a systematic review and meta-analysis.特应性皮炎与淋巴瘤风险：一项系统评价与荟萃分析。
Front Oncol. 2025 Apr 14;15:1580550. doi: 10.3389/fonc.2025.1580550. eCollection 2025.
6
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma.雌激素受体β刺激作为皮肤T细胞淋巴瘤可能的新型治疗靶点。
Blood Adv. 2025 Jun 10;9(11):2651-2662. doi: 10.1182/bloodadvances.2024015132.
7
Cutaneous T-cell lymphoma epidemiology: perspectives and updated prevalence data.皮肤T细胞淋巴瘤流行病学：观点与最新患病率数据。
Arch Dermatol Res. 2025 Feb 28;317(1):507. doi: 10.1007/s00403-025-04042-z.
8
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL).皮肤T细胞淋巴瘤（CTCL）新型全身治疗方法的进展
Curr Hematol Malig Rep. 2025 Jan 13;20(1):5. doi: 10.1007/s11899-024-00746-7.
9
Skin lymphomas in childhood: We only see what we know, we only know what we see.儿童皮肤淋巴瘤：我们只看到我们所知道的，我们只知道我们所看到的。
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):25-26. doi: 10.1111/jdv.20445.
10
Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.使用度普利尤单抗治疗特应性皮炎后皮肤T细胞淋巴瘤发生风险增加。
Dermatol Ther. 2024 Jan;2024. doi: 10.1155/2024/9924306. Epub 2024 Aug 14.
Zotero 插件